Previous studies demonstrated an independent association between higher circulating endogenous erythropoietin (EPO) levels and risk of all-cause and cardiovascular death among RTRs, similar to other patient populations such as chronic heart failure patients and the elderly [2,3,4]. The gene discussed is EPO; the disease is congestive heart failure.